Fluticasone lotion having improved vasoconstrictor activity

Details Fluticasone lotion having improved vasoconstrictor activity Fluticasone lotion having improved vasoconstrictor activity

2007-11-27

2007-11-27

Hui, San-Ming (Department: 1617)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

C424S485000, C424S486000, C514S177000

Reexamination Certificate

active

10800840

ABSTRACT:
A fluticasone lotion having improved vasoconstrictor and anti-inflammatory activity and higher than expected potency. The fluticasone lotion contains 0.05 weight percent fluticasone propionate and an oil-in-water vehicle that includes excipients. The fluticasone lotion is unexpectedly efficacious while exhibiting an improved safety profile.

REFERENCES:
patent: 4985418 (1991-01-01), Richards
patent: 0042827 (1981-12-01), None
patent: WO-9214472 (1992-09-01), None
patent: WO9214472 (1992-09-01), None
Gordon, Clinical Therapeutics, Feb. 1998; 20(1):26-39.
Budavari, Merck Index 11th ed. 1989, monograph 6021 and 7879.
Bleehen, S. S. et al: British Journal of Dermatology, vol. 133, No. 4, 1995, pp. 592-597.
Spencer, Caroline M et al: Biodrugs, vol. 7, No. 4, 1997, pp. 318-334.
“Physicians' Desk Reference monographs”, 7 pages.
“Potency Ranking of Some Commonly Used Topical Corticosteroids”,Temovate literature, 1 page.
Bleehan, S S., et al., “Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment.”,British Journal of Dermatology, 133(4), (1995),592-597.
Budavari, Susan , et al., “Monographs 6021 and 7879”,Merck Index 11th ed., Rahway, N.J. : Merck,(1989).
Cornell, Roger C., et al., “Potency Ranking of Some Commonly Used Topical Steroids”,Topical Corticosteroids—Guidelines for Therapy Hoechst-Roussel Pharmaceuticals Inc., (1985),24-25.
Gordon, M. L., “The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses.”,Clinical Therapeutics, 20(1), (Feb. 1998),26-39.
Spencer, Caroline M., “Topical Fluticasone Propionate: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders”,Biodrugs, 7(4), (1997),318-334.

Affiliated with

Also associated with

Rating

Fluticasone lotion having improved vasoconstrictor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fluticasone lotion having improved vasoconstrictor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluticasone lotion having improved vasoconstrictor activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3888222